ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Aurinia Pharmaceuticals Inc. Common shares, no par value (AUPH)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Aurinia Pharmaceuticals Inc. Common shares, no par value
Symbol: AUPH
Shares outstanding: 143,176,734 shares
Disclosed Ownership: 6,400,000 shares
Ownership: 4.47%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 17:05:03 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	4.47%	6,400,000	0	6,400,000	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	4.47%	6,400,000	0	6,400,000	/s/ Steven Boyd	Steven Boyd